The Scott M. Hammer Annual Update on HIV Management in New York, New York
Last Modified: Program Description This live course will be in person at the NYU Skirball Center. There will NOT be a simultaneous virtual component for this course, but the on-demand activity will be available a week following the course. This live course (more…)
The IAS–USA Annual Update on HIV Management in Atlanta, Georgia
Last Modified: Program Description This live course will be in person at the Cobb Galleria Centre. There will NOT be a simultaneous virtual component for this course, but the on-demand activity will be available a week following the course. This live course (more…)
The IAS–USA Annual Update on HIV Management in Chicago, Illinois
Last Modified: Program Description This live course will be in person at the Intercontinental Hotel. There will NOT be a simultaneous virtual component for this course, but the on-demand activity will be available a week (more…)
State-of-the-Art Update on Long COVID and HIV: Pathogenesis, Management, Clinical Trial Updates, and a Patient Perspective
Last Modified: Program Description This half-day course will include an overview of the clinical relationship between long COVID and HIV, a case-based panel discussion on the evaluation and management of long COVID, and updates on the latest clinical trials and ongoing gaps in knowledge. The (more…)
Implementation of Long-Acting Drugs for Treatment and Prevention of HIV
Last Modified: Program Description This half-day virtual course will include an overview of the challenges in the implementation of long-acting drugs for the treatment and prevention of HIV and explore the latest research on the use of long-acting drugs for the treatment and prevention of (more…)
The Annual IAS–USA Washington, DC, Virtual Course: Update on HIV Medicine Emerging Challenges
Last Modified: Program Description This comprehensive half-day virtual course will explore the emerging challenges in HIV medicine, including a discussion of the implications of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study, extending the discussion beyond the primary data. Topics include crucial aspects (more…)